David Devigne

David Devigne is an accomplished professional in the life sciences and venture capital sectors, currently serving as Investment Director at Korys since December 2021, where co-heads the health living/life sciences venture capital investment franchise and is a member of the management team and investment committee. Additionally, David holds the position of Senior Investment Advisor for the OMX Europe Venture Fund. In academia, David has been a Guest Professor at Vlerick Business School and Universiteit Gent since 2009 and 2016 respectively, while also pursuing a Ph.D. in Applied Economics focused on international venture capital dynamics. David's board memberships include Aphea.Bio, MIMETAS, Agendia, reMYND NV, ONTOFORCE, MRM Health, and MRM Technologies, reflecting significant involvement in the life sciences innovation landscape. David's educational background includes a Ph.D. in Applied Economics and multiple master's degrees in Pharmaceutical Sciences, Economics, and Business Administration from Ghent University and additional prestigious institutions.